Related Experiment Video
Updated: Jun 28, 2025

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer
Mary Kathryn Abel1,2,3, Ange Wang4, Joseph M Letourneau4,5
1San Francisco School of Medicine, University of California San Francisco, San Francisco, CA, USA. mabel@bwh.harvard.edu.
Purpose Of Review:
In this Perspective we share the personal story of a 33-year-old patient diagnosed with metastatic breast cancer and her journey through fertility preservation, surrogacy, and eventually motherhood, highlighting misconceptions about fertility preservation in this population.
Recent Findings:
There are nearly 1 million women under the age of 50 diagnosed and living with cancer in the USA. These patients are met with life-altering decisions, including those that may limit their reproductive ability. While there have been tremendous advances and advocacy in the field of oncofertility, there has been limited focus on patients with advanced stage or metastatic cancer. We describe five key misconceptions surrounding fertility preservation in patients with advanced stage cancer, offering a review of the literature and our approach to challenging topics like desiring fertility preservation in the face of Stage 4 disease, the safety and timing of ovarian stimulation during cancer treatment, and passing away following fertility preservation. We review the importance of assessing perceptions of fertility preservation in patients with metastatic cancer and highlight the lack of research in this area as a call to action.
Related Concept Videos
Infertility in Females
Endometriosis, a condition characterized by abnormal growth of...
Meiosis II
Targeted Cancer Therapies
There are several types of targeted therapies against...

